Patents by Inventor Fangbin HAN

Fangbin HAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of the retinoid-related orphan receptor gamma (ROR-gamma) for use in the treatment of autoimmune and inflammatory diseases
    Patent number: 10005731
    Abstract: The present invention relates to novel retinoid-related orphan receptor gamma (ROR?) modulators and their use in the treatment of diseases mediated by ROR?.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: June 26, 2018
    Assignee: Glaxo Group Limited
    Inventors: Fangbin Han, Hui Lei, Xichen Lin, Qinghua Meng, Yonghui Wang
  • Polysubstituted pyridine compound, preparation method, use and pharmaceutical composition
    Patent number: 9902709
    Abstract: The present invention provides a polysubstituted pyridine compound of Formula I, a preparation method, a use and a pharmaceutical composition thereof. The polysubstituted pyridine compound of Formula I according to the present invention has an excellent anti-tumor effect, can inhibit various cell kinases simultaneously, has significantly excellent pharmacokinetic characteristics, and is very suitable for oral and intravenous administration. The pharmaceutical composition according to the present invention can be useful for treating tumors and cancers.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: February 27, 2018
    Assignees: PEKING UNIVERSITY FOUNDER GROUP CO., LTD., PKUCARE PHARMACEUTICAL R & D CENTER, PKU HEALTHCARE INDUSTRY GROUP CO., LTD.
    Inventors: Chongqin Yi, Heng Xu, Jing Tao, Songwen Lin, Fangbin Han
  • POLYSUBSTITUTED PYRIDINE COMPOUND, PREPARATION METHOD, USE AND PHARMACEUTICAL COMPOSITION
    Publication number: 20170029404
    Abstract: The present invention provides a polysubstituted pyridine compound of Formula I, a preparation method, a use and a pharmaceutical composition thereof. The polysubstituted pyridine compound of Formula I according to the present invention has an excellent anti-tumor effect, can inhibit various cell kinases simultaneously, has significantly excellent pharmacokinetic characteristics, and is very suitable for oral and intravenous administration. The pharmaceutical composition according to the present invention can be useful for treating tumors and cancers.
    Type: Application
    Filed: December 30, 2014
    Publication date: February 2, 2017
    Inventors: Chongqin YI, Heng XU, Jing TAO, Songwen LIN, Fangbin HAN
  • MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR-GAMMA) FOR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
    Publication number: 20150299121
    Abstract: The present invention relates to novel retinoid-related orphan receptor gamma (ROR?) modulators and their use in the treatment of diseases mediated by ROR?.
    Type: Application
    Filed: December 5, 2013
    Publication date: October 22, 2015
    Applicant: Glaxo Group Limited
    Inventors: Fangbin HAN, Hui LEI, Xichen LIN, Qinghua MENG, Yonghui WANG